Metz, R.; Rauscher, A.; Vaugier, L.; Supiot, S.; Drouet, F.; Campion, L.; Rousseau, C.
Comparison of Hormone-Sensitive Oligorecurrent Prostate Cancer Patients Based on Routine Use of Choline and/or PSMA PET/CT to Guide Metastasis-Directed Therapy. Cancers 2023, 15, 1898.
https://doi.org/10.3390/cancers15061898
AMA Style
Metz R, Rauscher A, Vaugier L, Supiot S, Drouet F, Campion L, Rousseau C.
Comparison of Hormone-Sensitive Oligorecurrent Prostate Cancer Patients Based on Routine Use of Choline and/or PSMA PET/CT to Guide Metastasis-Directed Therapy. Cancers. 2023; 15(6):1898.
https://doi.org/10.3390/cancers15061898
Chicago/Turabian Style
Metz, Raphaël, Aurore Rauscher, Loïg Vaugier, Stéphane Supiot, Franck Drouet, Loic Campion, and Caroline Rousseau.
2023. "Comparison of Hormone-Sensitive Oligorecurrent Prostate Cancer Patients Based on Routine Use of Choline and/or PSMA PET/CT to Guide Metastasis-Directed Therapy" Cancers 15, no. 6: 1898.
https://doi.org/10.3390/cancers15061898
APA Style
Metz, R., Rauscher, A., Vaugier, L., Supiot, S., Drouet, F., Campion, L., & Rousseau, C.
(2023). Comparison of Hormone-Sensitive Oligorecurrent Prostate Cancer Patients Based on Routine Use of Choline and/or PSMA PET/CT to Guide Metastasis-Directed Therapy. Cancers, 15(6), 1898.
https://doi.org/10.3390/cancers15061898